NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON

Test your peptides at Ichor Life Sciences

70 tests published across 5 peptides from 41 vendors

first test 15 Jul 2026 · latest 21 Sep 2026

All partner labs →
Pass
14%

Pass rate on the most recent 50 tests under Finnrick’s Purity Focus methodology

Test my peptide samples for free →

Add Endotoxins and other options with our Standard testing.

About Ichor Life Sciences

Tests published
70
Latest test
21 Sep 2026
Location
Syracuse, NY
Instrumentation
HPLC

Ichor Life Sciences is a contract research organization founded in 2013 in the Finger Lakes region of New York, with roots in academic protein and structural-biology research. Finnrick partners with the lab for independent peptide testing — every sample is analyzed on calibrated, professionally operated equipment and returned as a formal Certificate of Analysis (COA) documenting exactly what was found.

See how Ichor Life Sciences answered our methodology questionnaire and how it compares to other partner labs.

Methodology Questionnaire

Responded 1 Sep 2026

A) Quantification Basis

1. Is reported quantity based on absolute calibration against a referencestandard, or relative/normalized signal?

Quantitation is performed using an external reference standard of the same target material. The entire reference-standard vial, typically containing material of high chromatographic purity, is reconstituted in a defined volume to prepare a concentrated stock solution. This stock is subsequently diluted to the target analytical concentration. The HPLC-UV peak area of the test sample is compared with the peak area of the matched reference standard, and the sample concentration is calculated from the peak-area ratio and applicable dilution factors. The calculated concentration is then used to determine the inferred amount of peptide in the test vial.

2. Do you average replicate injections or preparations before reporting a singlevalue?

The reference standard is analyzed in replicate at the beginning of the assay to evaluate injection repeatability and system suitability. The acceptance criterion is ≤1% RSD for reference-standard peak area and retention time. Test samples are normally analyzed using a single injection. If a test-sample response differs substantially from the matched reference standard, including a difference greater than approximately 20%, the result is reviewed and the sample may be re-prepared and/or re-analyzed to confirm the result.

B) Sample Preparation

3. Do you assume full recovery of peptide upon reconstitution, or do you measure recovery implicitly?

Full recovery is assumed.

4. Do you correct for adsorption, losses, or degradation, or are these reflected in the final number?

No correction factors are applied for adsorption, incomplete recovery, handling losses, or degradation. Any such losses that occur before HPLC analysis would generally reduce the measured target-peptide concentration and therefore be reflected in the reported result. Samples are maintained under refrigerated or frozen storage conditions appropriate for the target and are analyzed promptly after reconstitution to minimize these effects; however, the magnitude of these potential losses is not independently measured as part of the routine assay.

C) Detection & Calculation

5. Which detector(s) are used for quantification (UV, MS, both), and which signal is authoritative for quantity?

HPLC-UV is the quantitative method. For peptide samples, a photodiode-array UV detector is operated at 215 nm to monitor peptide-bond absorbance, and the integrated target-peak area at this wavelength is used for quantitative calculations. For non-peptide targets, an alternative quantitation wavelength may be selected based on the UV absorbance spectrum of the analyte. Mass spectrometry is used as an orthogonal identity-confirmation method and is not used for quantitative determination in this assay. Peptide samples are analyzed by direct infusion under positive electrospray-ionization conditions, and the experimentally determined neutral monoisotopic mass is compared with the theoretical monoisotopic mass calculated from the peptide sequence.

6. How is purity incorporated into quantity (e.g., normalization vs independent measurement)?

Purity and quantitative content are determined independently. Chromatographic purity is calculated as the integrated area of the target peptide peak divided by the total integrated area of detected chromatographic peaks and is reported as an HPLC-UV area percentage. Quantitative content is determined separately by comparing the target peptide peak area with that of the external reference standard. The chromatographic purity percentage is therefore not applied as a correction or normalization factor to the calculated peptide content.

D) Precision & Uncertainty

7. What is your stated margin of error for this peptide, and does it include preparation + calibration uncertainty?

A formal overall measurement uncertainty or margin of error has not been established for this assay. The ≤1% RSD system-suitability criterion applies to replicate reference-standard injections and represents instrument/injection repeatability; it should not be interpreted as a ±1% uncertainty for the reported peptide content. Overall assay uncertainty would additionally include contributions from reference-standard assignment, standard and sample preparation, reconstitution volume, dilution accuracy, recovery, chromatographic integration, and between-run variability.

8. Are reported values rounded, truncated, or raw calculated outputs?

Reported quantitative values are rounded to the stated number of decimal places rather than reported as unrounded instrument outputs. For the current reporting format, HPLC purity and peptide content are generally reported to two decimal places. Calculations are performed using the underlying unrounded values before the final result is rounded for reporting.

E) Interpretation

9. Does your reported “mg per vial” represent recovered mass, inferred mass, or label-equivalent mass?

The reported mg-per-vial value represents the analytically inferred amount of target peptide in the vial. The concentration of peptide measured in the reconstituted solution by comparison with the external reference standard is multiplied by the known reconstitution volume and applicable dilution factors to calculate the corresponding total mass in the original vial. It is not a direct gravimetric measurement of recovered peptide mass. Because quantitative recovery during reconstitution is assumed, losses caused by incomplete dissolution, adsorption, degradation, or sample handling are not independently corrected.

10. Under what conditions would you expect two vials from the same batch to differ by <1%?

Two vials from the same batch would be expected to produce results within 1% of one another only where both the manufacturing process and the analytical method demonstrate sufficiently low variability. The current RSD criterion for replicate standard injections alone is not sufficient to establish that true vial-to-vial differences below 1% can be reliably resolved. A less than 1% variability could occur in identically filled vessels as a results of handling and storage conditions, and minor solvent delivery variations in the equipment used for reconstitution and dilution of the standards or analytical samples.

What you’ll learn

Ichor Life Sciences runs your samples through HPLC analysis, and sends back a certificate of analysis, detailing test results. Computed through your choice of Finnrick safety standards, this sample is then declared as “passing” or “failing”, depending on the answers to three critical questions:

Identity

Is this actually what the label claims, or something else entirely?

Purity

Are there other peptides, proteins, or contaminants mixed in with your compound?

Quantity

Did you receive the amount of active ingredient you paid for, or are you dosing based on wishful thinking?

HPLC is the standard analytical method for peptide characterization, used across research institutions and commercial labs worldwide.

Tests Ichor Life Sciences can run

Peptides Ichor Life Sciences can test

How Finnrick publishes results

Finnrick publishes results when we can establish sample provenance and have enough evidence that the sample represents the product sold by the named vendor. Published results include vendor and product details, helping customers evaluate the available evidence and encouraging better supply-chain decisions.

Results that do not meet these requirements are shared with the requester and kept outside the public record. Read how Finnrick decides which results to publish →

Don’t want to share sample details?

The Confidential option costs an additional $99 per sample in Custom, on top of Basic testing, any product surcharge and selected tests. Standard already includes Confidential. Results are shared with you and not published publicly.

Frequently asked questions

Can I test my peptides at Ichor Life Sciences?

Choose Ichor Life Sciences in Custom when it is available for your product and selected tests. The current options are shown below. The Confidential option is a paid Custom add-on and is included in Standard.

What does Ichor Life Sciences test for?

See the current test options on this page. Availability and total price depend on your product, lab and selected tests; Basic testing is required.

Are Ichor Life Sciences results independent and trustworthy?

Samples sent through Finnrick are anonymized before they reach the lab. Finnrick reviews lab performance using overlapping results and independently obtained anchor samples. Results are published only when sample provenance meets Finnrick's publication requirements.

How many Ichor Life Sciences test results has Finnrick published?

70 published results to date, across 5 peptides and 41 vendors. However, not all tests Finnrick has commissioned from this lab have been published: more about our publishing policy.

Test my peptide samples for free →

Add Endotoxins and other options with our Standard testing.

Do you distribute peptides?

Finnrick offers professional testing services for vendors who want to verify their supply chain and build trust with customers through independent quality assurance.

Learn about vendor services